Diabetes Treatment Devices Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Diabetes Treatment Devices Market Expected To Expand Between 2025 And 2029?

The diabetes treatment devices market size has experienced strong growth in recent years. It is forecast to grow from $11.61 billion in 2024 to $12.34 billion in 2025, at a compound annual growth rate (CAGR) of 6.3%. This historical growth can be attributed to the increasing prevalence of diabetes, heightened awareness about diabetes management, the growing adoption of insulin delivery devices, rising healthcare expenditure in developing countries, and the increasing availability of advanced glucose monitoring systems.

The diabetes treatment devices market size is projected to experience substantial expansion in the coming years, with expectations to reach $15.61 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.1%. This anticipated growth over the forecast period is attributable to several key factors, including the escalating demand for wearable and non-invasive monitoring devices, a rising focus on personalized diabetes care, the increasing adoption of digital health platforms and applications, a growing need for remote diabetes management solutions, and greater governmental initiatives aimed at promoting diabetes control programs. Concurrently, major trends expected during this period involve significant advancements in continuous glucose monitoring technology, the development of sophisticated insulin delivery systems integrated with artificial intelligence, the creation of smart wearable diabetes devices, innovation in non-invasive blood sugar monitoring methods, and the integration of voice assistants into device operations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Diabetes Treatment Devices Industry?

The future expansion of the diabetes treatment devices market is anticipated due to escalating obesity rates. An individual’s body mass index (BMI) is used to determine the obesity rate, which indicates the proportion of people categorized as obese. A primary cause of these escalating obesity rates is diets rich in calories, sugars, and fats, resulting in significant weight gain without adequate physical exercise. By facilitating improved blood sugar management, diabetes treatment devices contribute to lowering obesity rates, thereby encouraging healthier lifestyles and effective weight control. For example, data from the Centers for Disease Control and Prevention, a US-based government agency, revealed in September 2023 that 22 U.S. states recorded an adult obesity rate of 35% or higher in 2022, an increase from 19 states in 2021. Consequently, the expanding obesity rates are fueling the development of the diabetes treatment devices market.

What Are The Major Segment Categories Driving The Diabetes Treatment Devices Market Growth?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

What Long-Term Trends Will Shape The Future Growth Of The Diabetes Treatment Devices Industry?

Major companies in the diabetes treatment devices market are concentrating on developing innovative solutions, such as hybrid closed-loop insulin pump systems, to enhance glycemic control and lessen the burden of diabetes management for patients. A hybrid closed-loop insulin pump system is an advanced diabetes device that automatically adjusts insulin delivery based on continuous glucose monitor (CGM) readings, while requiring users to manually input mealtime insulin doses. For instance, in March 2022, Medtronic PLC, an Ireland-based medical device company, introduced the MiniMed 780G system, featuring SmartGuard technology for managing type 1 diabetes in individuals aged 7 to 80 years. This sophisticated system automatically regulates basal insulin and delivers correction boluses every five minutes to help maintain glucose levels within a personalized target range, even compensating for missed meal boluses or incorrect carbohydrate estimates. It also includes Meal Detection technology, a continuous glucose monitor that eliminates the need for fingersticks, and an infusion set designed for up to seven days of wear, all of which are accessible and manageable through a connected mobile app.

Who Are The Core Companies Influencing The Diabetes Treatment Devices Market Landscape?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Eli Lilly And Company, Novo Nordisk A/S, Becton, Dickinson And Company, Hoffmann-La Roche Ltd., Insulet Corporation, DexCom Inc., Tandem Diabetes Care Inc, Lifescan Inc., Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc., Bigfoot Biomedical Inc., Medtrum Technologies Inc., Diabeloop SA, Roche Diabetes Care GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Diabetes Treatment Devices Market?

North America was the largest region in the diabetes treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Diabetes Treatment Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2025, By The Business Research Company

Diabetes Care Devices Market 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Pet Diabetes Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Insulin Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795